Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

CAPS Rating: 3 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Recs

0
Player Avatar bmk2 (35.61) Submitted: 1/5/2011 4:10:02 PM : Outperform Start Price: $36.84 VRTX Score: +72.54

If their drugs in development work, this will be like Viagra was to Pfizer

Report this Post Reply

Featured Broker Partners


Advertisement